Electronic patient-reported outcome

CloudWave Partners with MEDITECH International to Deliver Expanse EPR Services for More than Half a Million Patients Across the UK

Retrieved on: 
Tuesday, January 10, 2023
Data Management, Security, Health, Technology, Health Technology, Internet, Cloud, Hospital, Electronic patient-reported outcome, National Health Service, Expanse, East Cheshire NHS Trust, EPR, Partnership, Patient, Trust, EHR, National Health Service (England), MEDITECH, NHS, Mid Cheshire Hospitals NHS Foundation Trust

CloudWave , the expert in healthcare data security, today announced that MEDITECH UK has chosen CloudWave’s OpSus Cloud Services to power its MEDITECH Expanse EPR (Electronic Patient Record) and MEDITECH Cloud Hosted offering to East Cheshire NHS Trust and Mid Cheshire Hospitals NHS Foundation Trust.

Key Points: 
  • CloudWave , the expert in healthcare data security, today announced that MEDITECH UK has chosen CloudWave’s OpSus Cloud Services to power its MEDITECH Expanse EPR (Electronic Patient Record) and MEDITECH Cloud Hosted offering to East Cheshire NHS Trust and Mid Cheshire Hospitals NHS Foundation Trust.
  • They will be working with CloudWave and MEDITECH to deploy a cloud-based electronic health record (EHR) solution customized for a population of more than 550,000 patients across the UK.
  • MEDITECH and CloudWave’s collaborative design for an international MEDITECH Cloud Hosted EPR system provides a cost-effective and scalable way for hospitals to access the Expanse EPR.
  • This partnership will enable East and Mid Cheshire to deliver the MEDITECH Expanse EPR leveraging trusted resources in the public cloud, backed with the delivery expertise, security, management, and depth of support from CloudWave.

Global Electronic Clinical Outcome Assessment Solutions Market (2022 to 2030) - Size, Share & Trends Analysis Report - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 8, 2022
Health, General Health, Cloud, Clinical data management, Electronic patient-reported outcome, IQVIA, Chapter Three, Guest appearance, Disease, Solution, Growth, Patient, Health, Cros, COVID-19, Compliance, Adoption, EPRO, Clinical trial, Pharmaceutical industry, Medical imaging

This boosted demand for eClinical solutions including electronic clinical outcome assessment (eCOA) solutions.

Key Points: 
  • This boosted demand for eClinical solutions including electronic clinical outcome assessment (eCOA) solutions.
  • As patients were unable to visit trial sites, eCOA solutions emerged as a reliable solution to collect patient data.
  • Contract research organizations dominated the electronic clinical outcome assessment solutions market as major pharmaceutical companies are focused on reducing expenditure on clinical trials.
  • Electronic Clinical Outcome Assessment Solutions Market Variables, Trends & Scope

Axiom Exhibiting at Outsourcing in Clinical Trials Southeast 2022

Retrieved on: 
Wednesday, March 23, 2022
Adoption, Axiom, DM, Unified, Clinical trial, IRT, Suite, Metric, Clinical data management, Technology, CTMS, Data management, Service, Patient, GLOBE, EDC, Solution, VP, EPRO, Electronic patient-reported outcome, Pharmaceutical industry, Pharmacovigilance, Biostatistics

TORONTO, March 23, 2022 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at Outsourcing in Clinical Trials Southeast 2022, March 29-30 in Raleigh, North Carolina.

Key Points: 
  • TORONTO, March 23, 2022 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at Outsourcing in Clinical Trials Southeast 2022, March 29-30 in Raleigh, North Carolina.
  • The 11th annual edition of the conference brings together over 120 clinical operations executives to connect and explore the steps that are being taken to improve clinical trial operations.
  • This educational and innovative conference will allow attendees to explore solutions to current challenges associated with clinical trials and learn methods to optimize trial success.
  • IRT solutions are an essential part of the roadmap to getting clinical studies successfully delivered, says Heather DiFruscia, VP RTSM.

Global ePRO, E-Patient Diaries and eCOA Market Trajectory & Analytics Research Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 2, 2022
Biotechnology, General Health, Medical Devices, Health, Pharmaceutical, Awareness, Growth, Conditional sentence, Trial of the century, Internet, Biotechnology, Technology, COVID-19, Person, Shadow King, CAGR, Pressure, Method, Prevalence, EPRO, Privacy, Vaccine, Guest appearance, Drug development, Severe acute respiratory syndrome coronavirus 2, Electronic patient-reported outcome, Pharmaceutical industry

The "ePRO, E-Patient Diaries and eCOA - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "ePRO, E-Patient Diaries and eCOA - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Growth in the market is also being driven by the continuous rise in demand for clinical trials and research studies to develop new drugs, therapies and vaccines.
  • Also, since there are more people using smartphones, therefore there is greater acceptability of eCOA and ePRO methods.
  • This segment currently accounts for a 21.6% share of the global ePRO, E-Patient Diaries and eCOA market.

Global EPRO, ePatient Diaries, and eCOA Market (2021 to 2027) - Size, Trends & Growth Opportunities - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 21, 2021
Health, Other Health, Drug discovery, Guest appearance, Observer, Patient, Adoption, Contract, Electronic patient-reported outcome, Market, Laika (EHR testing framework), Drug development, Research, Health information management, Academic institution, EPRO, Cros, University, Growth, Oil, Pharmaceutical industry, Landscape maintenance, Hospital, Industry

The increase in adoption of ePRO, ePatient Diaries, and eCOA by medical research professionals is expected to boost the global ePRO, ePatient Diaries, and eCOA market growth throughout the forecast period.

Key Points: 
  • The increase in adoption of ePRO, ePatient Diaries, and eCOA by medical research professionals is expected to boost the global ePRO, ePatient Diaries, and eCOA market growth throughout the forecast period.
  • In addition, the increase in demand for EHRs (electronic health records) and the rise in use of smartphones are support the global ePRO, ePatient Diaries, and eCOA market growth.
  • The increase in concerns regarding data privacy is a major restraining factor which expected to hamper the growth of the global ePRO, ePatient Diaries, and eCOA market throughout the forecast period.
  • What are the Key Opportunities in Global EPRO, ePatient Diaries, and eCOA Market?

Valued to be $2.8 Billion by 2026, ePRO, E-Patient Diaries and eCOA Slated for Robust Growth Worldwide

Retrieved on: 
Tuesday, October 5, 2021
Geography, Academic institution, Person, CAGR, Privacy, Parexel, Growth, Electronic patient-reported outcome, GIA, Kane Epati, SAN, Intelligence, Biotechnology, Vaccine, Awareness, Players, Technology, Conditional sentence, Patient, Guest appearance, Shadow King, Clinical trial, Internet, EPRO, Pressure, COVID-19, Marketing, Method, ICON, Cros, Medidata Solutions, Severe acute respiratory syndrome coronavirus 2, Forecasting, Prevalence, Trial of the century, Research, Drug development, Contract, Pharmaceutical industry, Pet

We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies.

Key Points: 
  • We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies.
  • Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more.
  • Preview Registry
    ePRO, eCOA, and e-patient diaries are among the technologies that are enabling healthcare providers and clinical trial companies to enable electronic data capture and analysis.
  • This segment currently accounts for a 21.6% share of the global ePRO, E-Patient Diaries and eCOA market.

North America Electronic Clinical Outcome Assessment Market 2020-2021 & 2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 14, 2021
Technology, General Health, Health, Data management, Health, Clinical data management, Quality of life, Clinical research, Articles, Health informatics, Electronic patient-reported outcome, EPRO, Patient-reported outcome, Medical record, Clinical trial

b'The "North America Electronic Clinical Outcome Assessment Market By Delivery Mode, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe US market dominated the North America Licensed enterprises eCOA Market by Country in 2019, thereby, achieving a market value of $69.8 Million by 2026.\nWith an aim to collect patient data during clinical trials & observation studies, there is high utilization of eCOAs, including electronic ClinROs (Clinician Reported Outcomes), ObsROs (Observer Reported Outcomes), and ePROs (electronic Patient Reported Outcomes).

Key Points: 
  • b'The "North America Electronic Clinical Outcome Assessment Market By Delivery Mode, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe US market dominated the North America Licensed enterprises eCOA Market by Country in 2019, thereby, achieving a market value of $69.8 Million by 2026.\nWith an aim to collect patient data during clinical trials & observation studies, there is high utilization of eCOAs, including electronic ClinROs (Clinician Reported Outcomes), ObsROs (Observer Reported Outcomes), and ePROs (electronic Patient Reported Outcomes).
  • Therefore, the market growth is anticipated to be fuelled due to these consistent technological advancements to offer an effective workflow.
  • Using ePRO systems, real-time data of patients can be transferred from the patients to healthcare professionals with an aim for precise decision-making and the right assessment of a patient\'s health.
  • Also, the market growth is driven by the growing deployment of eCOA by medical research professionals.\nMarket Segments covered in the Report:\n'

eCOA/ePRO Market Dynamics and Service Provider Performance, 2020 Report - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 6, 2021
Professional services, Other Professional Services, Clinical data management, Quality of life, Electronic patient-reported outcome, EPRO, ERT, Articles, Health, Evaluation, Equal Credit Opportunity Act

The "eCOA/ePRO Market Dynamics and Service Provider Performance (4th Edition)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "eCOA/ePRO Market Dynamics and Service Provider Performance (4th Edition)" report has been added to ResearchAndMarkets.com's offering.
  • There's no question that technology is continuously becoming more prevalent in the clinical development space and electronic clinical outcomes assessments (eCOA) and electronic patient reported outcomes (ePRO) systems are no exception.
  • The publisher has been tracking the eCOA/ePRO market for over a decade and one thing is for certain - eCOA/ePRO applications are here to stay.
  • As technology in the eCOA/ePRO space continues to change, more sponsors and CROs rely on these systems to ensure high quality data, lower costs, and fewer delays.

Mednet Launches New and Expanded ePRO Functionality

Retrieved on: 
Wednesday, December 16, 2020
Computing, Clinical data management, Quality of life, Electronic patient-reported outcome, EPRO, Science and technology, Tablet computer, Mobile device, Responsive web design, Computers

MINNEAPOLIS, Dec. 16, 2020 /PRNewswire/ --Today Mednet, a healthcare technology company, announced its latest software release featuring expanded electronic patient reported outcomes (ePRO) capabilities.

Key Points: 
  • MINNEAPOLIS, Dec. 16, 2020 /PRNewswire/ --Today Mednet, a healthcare technology company, announced its latest software release featuring expanded electronic patient reported outcomes (ePRO) capabilities.
  • The new Mednet module is the result of a year-long development process designed to significantly improve the user experience of Mednet's ePRO capability, including fully optimizing the module for mobile tablets.
  • Mednet ePRO incorporates a responsive design, enabling it to be used on a variety of mobile devices, adapting to the specific orientation of the device.
  • Mednet will continue to maintain its desktop ePRO version for patients signing in from desktop applications.

Healint Starts Third Virtual Clinical Trial Amid COVID-19 Pandemic

Retrieved on: 
Wednesday, November 18, 2020
Clinical research, Health sciences, Pharmaceutical industry, Health, Medical research, Clinical trials, Design of experiments, Migraine, Patient recruitment, Electronic patient-reported outcome

NEW YORK, Nov. 18, 2020 /PRNewswire/ -- Healint , a leading provider of healthcare technology and developer of the Migraine Buddy tracking app, is now recruiting patients for its third virtual global clinical trial in the past two years.

Key Points: 
  • NEW YORK, Nov. 18, 2020 /PRNewswire/ -- Healint , a leading provider of healthcare technology and developer of the Migraine Buddy tracking app, is now recruiting patients for its third virtual global clinical trial in the past two years.
  • With COVID-19 reducing the ability of patients to visit medical facilities and clinical trial sites in person and after the successful completion of its first two virtual trials with the world's largest research-based pharmaceutical leaders, Healint is utilizing its industry leading virtual clinical trial capabilities to recruit patients to participate in a new trial for ePRO measures for an acute migraine medication.
  • Moving clinical trials to a virtual setting also eliminates the need for in-person patient or nurse visits, cumbersome paper records, and armies of clinical research associates to monitor the accuracy of patient data.
  • Recruitment for Healint's third virtual trial will conclude by the third quarter of 2021, and the trial is expected to last for eight to twelve months.